Emtricitabine-tenofv 200-300MG UU 30S
Ended Awarded
- Contract number
- SPE2DX25FUXAL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,323
Award facts
- Contract value 100% obligated
- $3,323.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units, with a ceiling value of $3,323.16. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The award was competitively procured with no set-aside designation, leveraging AmerisourceBergen's capability as a major pharmaceutical distributor to the federal medical procurement system. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary contract vehicle for pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order reflects the company's ongoing role in supporting military healthcare logistics and represents one of numerous small-to-medium value pharmaceutical transactions executed under the broader DLA Troop Support Medical IDC framework.
Quick answers
Who was awarded contract SPE2DX25FUXAL?
SPE2DX25FUXAL was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 14, 2025.
How much is contract SPE2DX25FUXAL worth?
The government has obligated $3,323 on SPE2DX25FUXAL.
Is contract SPE2DX25FUXAL an order under another contract?
Yes. SPE2DX25FUXAL is a delivery order under SPE2DX15D3026, an indefinite delivery contract.
Was contract SPE2DX25FUXAL competed?
The extent of competition for SPE2DX25FUXAL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award